← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 1, 2006Last known activity
Jul 28, 2023
Timeline
1990s
- Jun 1, 1997
Sequella, Inc.— Founded
Drugs by trial phase (14 distinct, 9 trials)
Phase 3 (8 own, 0 via acquisition)
Phase 2 (5 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (12)
- NCT05686356CollaboratorPhase 2/Phase 3Jul 28, 2023
- NCT03959566CollaboratorPhase 2Aug 31, 2019
- NCT01785186CollaboratorPhase 2Apr 1, 2013
- NCT01252108Lead sponsorPhase 2Mar 1, 2012
- NCT01225640Study directorPhase 2Aug 1, 2011
- NCT01225640Lead sponsorPhase 2Aug 1, 2011
- NCT01218217CollaboratorPhase 2Nov 1, 2010
- NCT00990990Lead sponsorPhase 1Oct 1, 2009
- NCT00990990Study directorPhase 1Oct 1, 2009
- NCT00871949Study directorPhase 1Apr 1, 2009
- NCT00871949Lead sponsorPhase 1Apr 1, 2009
- NCT01585636Lead sponsorPhase 1Sep 1, 2006
Details
- Founded
- Washington DC, US Jun 1, 1997
- Last known activity
- Jul 28, 2023